Nutrient intake, nutritional status, and cognitive function with aging

Annals of the New York Academy of Sciences

Volumn 1367, Issue 1, 2016, Pages 38-49

  Tucker, Katherine L ^a  

^a UNIVERSITY OF MASSACHUSETTS LOWELL   (United States)

Author keywords

Aging; Cognitive decline; Cognitive function; Dietary intake; Nutrition

Indexed keywords

ALPHA TOCOPHEROL; CARBOHYDRATE; FLAVONOID; OMEGA 3 FATTY ACID; SATURATED FATTY ACID; TRANS FATTY ACID; VITAMIN B GROUP; VITAMIN D; ANTIOXIDANT; VITAMIN B COMPLEX;

AGING; ARTICLE; ATHEROSCLEROSIS; COGNITION; COGNITIVE DEFECT; DIETARY INTAKE; FISH; FOOD; FRUIT; GLYCEMIC CONTROL; HUMAN; HYPERTENSION; NUT; NUTRIENT; NUTRIENT INTAKE; NUTRITIONAL STATUS; PLANT SEED; SUPPLEMENTATION; VEGETABLE; ANIMAL; BRAIN; CALORIC INTAKE; DIET THERAPY; DRUG EFFECTS; METABOLISM; PHYSIOLOGY;

AGING; ANIMALS; ANTIOXIDANTS; BRAIN; COGNITION; COGNITION DISORDERS; ENERGY INTAKE; FATTY ACIDS, OMEGA-3; HUMANS; NUTRITIONAL STATUS; VITAMIN B COMPLEX; VITAMIN D; VITAMIN E;

EID: 84964908757     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/nyas.13062     Document Type: Article

References (99)

1. Schaller, S., J. Mauskopf, C. Kriza, et al. 2015. The main cost drivers in dementia: a systematic review. Int. J. Geriatr. Psychiatry 30: 111-129.
2. Plassman, B.L., K.M. Langa, G.G. Fisher, et al. 2007. Prevalence of dementia in the United States: the aging, demographics, and memory study. Neuroepidemiology 29: 125-132.
3. Hebert, L.E., J. Weuve, P.A. Scherr & D.A. Evans . 2013. Alzheimer disease in the United States (2010-2050) estimated using the 2010 census. Neurology 80: 1778-1783.
4. Murphy, R.A., E.A. Yu, E.D. Ciappio, et al. 2015. Suboptimal plasma long chain n-3 concentrations are common among adults in the United States, NHANES 2003-2004. Nutrients 7: 10282-10289.
5. Neuringer, M., G.J. Anderson, W.E. Connor . 1988. The essentiality of n-3 fatty acids for the development and function of the retina and brain. Annu. Rev. Nutr. 8: 517-541.
6. Ervin, R.B., J.D. Wright, C.Y. Wang & J. Kennedy-Stephenson . 2004. Dietary intake of fats and fatty acids for the United States population: 1999-2000. Adv. Data 348: 1-6.
7. Kalmijn, S., M.P. van Boxtel, M. Ocke, et al. 2004. Dietary intake of fatty acids and fish in relation to cognitive performance at middle age. Neurology 62: 275-280.
8. Morris, M.C., D.A. Evans, C.C. Tangney, et al. 2005. Fish consumption and cognitive decline with age in a large community study. Arch. Neurol. 62: 1849-1853.
9. Barberger-Gateau, P., L. Letenneur, V. Deschamps, et al. 2002. Fish, meat, and risk of dementia: cohort study. BMJ 325: 932-933.
10. Morris, M.C., D.A. Evans, J.L. Bienias, et al. 2003. Consumption of fish and n-3 fatty acids and risk of incident Alzheimer disease. Arch. Neurol. 60: 940-946.
11. Huang, T.L., P.P. Zandi, K.L. Tucker, et al. 2005. Benefits of fatty fish on dementia risk are stronger for those without APOE ε4. Neurology 65: 1409-1414.
12. Barberger-Gateau, P., C. Raffaitin, L. Letenneur, et al. 2007. Dietary patterns and risk of dementia: the Three-City cohort study. Neurology 69: 1921-1930.
13. Morris, M.C., J. Brockman, J.A. Schneider, et al. 2016. Association of seafood consumption, brain mercury level, and APOE ε4 status with brain neuropathology in older adults. JAMA 315: 489-497.
14. Conquer, J.A., M.C. Tierney, J. Zecevic, et al. 2000. Fatty acid analysis of blood plasma of patients with Alzheimer's disease, other types of dementia, and cognitive impairment. Lipids 35: 1305-1312.
15. Tully, A.M., H.M. Roche, R. Doyle, et al. 2003. Low serum cholesteryl ester-docosahexaenoic acid levels in Alzheimer's disease: a case-control study. Br. J. Nutr. 89: 483-489.
16. Soderberg, M., C. Edlund, K. Kristensson & G. Dallner . 1991. Fatty acid composition of brain phospholipids in aging and in Alzheimer's disease. Lipids 26: 421-425.
17. Lin, P.Y., C.C. Chiu, S.Y. Huang & K.P. Su . 2012. A meta-analytic review of polyunsaturated fatty acid compositions in dementia. J. Clin. Psychiatry 73: 1245-1254.
18. Heude, B., P. Ducimetiere, C. Berr ; E.V.A. Study . 2003. Cognitive decline and fatty acid composition of erythrocyte membranes-the EVA Study. Am. J. Clin. Nutr. 77: 803-808.
19. Schaefer, E.J., V. Bongard, A.S. Beiser, et al. 2006. Plasma phosphatidylcholine docosahexaenoic acid content and risk of dementia and Alzheimer disease: the Framingham Heart Study. Arch. Neurol. 63: 1545-1550.
20. Bucher, H.C., P. Hengstler, C. Schindler & G. Meier . 2002. N-3 polyunsaturated fatty acids in coronary heart disease: a meta-analysis of randomized controlled trials. Am. J. Med. 112: 298-304.
21. Mazereeuw, G., K.L. Lanctot, S.A. Chau, et al. 2012. Effects of omega-3 fatty acids on cognitive performance: a meta-analysis. Neurobiol. Aging 33: e17-e29.
22. Fotuhi, M., P. Mohassel & K. Yaffe . 2009. Fish consumption, long-chain omega-3 fatty acids and risk of cognitive decline or Alzheimer disease: a complex association. Nat. Clin. Pract. Neurol. 5: 140-152.
23. Witte, A.V., L. Kerti, H.M. Hermannstadter, et al. 2014. Long-chain omega-3 fatty acids improve brain function and structure in older adults. Cereb. Cortex 24: 3059-3068.
24. Yurko-Mauro, K., D. McCarthy, D. Rom, et al. 2010. Beneficial effects of docosahexaenoic acid on cognition in age-related cognitive decline. Alzheimers Dement. 6: 456-464.
25. Hashimoto, M. & S. Hossain . 2011. Neuroprotective and ameliorative actions of polyunsaturated fatty acids against neuronal diseases: beneficial effect of docosahexaenoic acid on cognitive decline in Alzheimer's disease. J. Pharmacol. Sci. 116: 150-162.
26. Quinn, J.F., R. Raman, R.G. Thomas, et al. 2010. Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial. JAMA 304: 1903-1911.
27. Tucker, K.L., N. Qiao, T. Scott, et al. 2005. High homocysteine and low B vitamins predict cognitive decline in aging men: the Veterans Affairs Normative Aging Study. Am. J. Clin. Nutr. 82: 627-635.
28. Mooijaart, S.P., J. Gussekloo, M. Frolich, et al. 2005. Homocysteine, vitamin B-12, and folic acid and the risk of cognitive decline in old age: the Leiden 85-Plus study. Am. J. Clin. Nutr. 82: 866-871.
29. 12 as predictors of cognitive function and decline in older high-functioning adults: MacArthur Studies of Successful Aging. Am. J. Med. 118: 161-167.
30. 12, and homocysteine as risk factors for cognitive decline in the elderly. Psychiatry Investig. 5: 36-40.
31. Seshadri, S., A. Beiser, J. Selhub, et al. 2002. Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N. Engl. J. Med. 346: 476-483.
32. Lindenbaum, J., E.B. Healton, D.G. Savage, et al. 1988. Neuropsychiatric disorders caused by cobalamin deficiency in the absence of anemia or macrocytosis. N. Engl. J. Med. 318: 1720-1728.
33. Healton, E.B., D.G. Savage, J.C. Brust, et al. 1991. Neurologic aspects of cobalamin deficiency. Medicine (Baltimore) 70: 229-245.
34. Selhub, J., M.S. Morris, P.F. Jacques & I.H. Rosenberg . 2009. Folate-vitamin B-12 interaction in relation to cognitive impairment, anemia, and biochemical indicators of vitamin B-12 deficiency. Am. J. Clin. Nutr. 89: 702S-706S.
35. Morris, M.S., P.F. Jacques, I.H. Rosenberg & J. Selhub . 2007. Folate and vitamin B-12 status in relation to anemia, macrocytosis, and cognitive impairment in older Americans in the age of folic acid fortification. Am. J. Clin. Nutr. 85: 193-200.
36. Tucker, K.L., S. Rich, I. Rosenberg, et al. 2000. Plasma vitamin B-12 concentrations relate to intake source in the Framingham Offspring study. Am. J. Clin. Nutr. 71: 514-522.
37. Krasinski, S.D., R.M. Russell, I.M. Samloff, et al. 1986. Fundic atrophic gastritis in an elderly population. Effect on hemoglobin and several serum nutritional indicators. J. Am. Geriatr. Soc. 34: 800-806.
38. Dharmarajan, T.S., M.R. Kanagala, P. Murakonda, et al. 2008. Do acid-lowering agents affect vitamin B12 status in older adults? J. Am. Med. Dir. Assoc. 9: 162-167.
39. 12, Pantothenic Acid, Biotin, and Choline. Washington, DC: National Academies Press.
40. 6." In Modern Nutrition in Health and Disease. 11th ed. A.C. Ross, B. Caballero, R.J. Cousins, K.L. Tucker & T.R. Ziegler, Eds.: 341-350. Philadelphia, PA: Lippincott Williams & Wilkins.
41. Schroeder, H.A. 1971. Losses of vitamins and trace minerals resulting from processing and preservation of foods. Am. J. Clin. Nutr. 24: 562-573.
42. CDC, National Center for Environmental Health. 2012. Second national report on biochemical indicators of diet and nutrition in the U.S. population 2012 executive summary. http://www.cdc.gov/nutritionreport/pdf/exesummary_web_032612.pdf.
43. 6 from diet and supplements in relation to risk of coronary heart disease among women. JAMA 279: 359-364.
44. Folsom, A.R., F.J. Nieto, P.G. McGovern, et al. Prospective study of coronary heart disease incidence in relation to fasting total homocysteine, related genetic polymorphisms, and B vitamins: the Atherosclerosis Risk in Communities (ARIC) study. Circulation 98: 204-210.
45. 12 and the risk of CHD: the Japan Public Health Center-Based Prospective Study Cohort I. J. Am. Coll. Nutr. 27: 127-136.
46. 6 level is associated with symptoms of depression. Psychother. Psychosom. 73: 340-343.
47. 6 is associated with depressive symptomatology in Massachusetts elders. J. Am. Coll. Nutr. 27: 421-427.
48. Smith, A.D., S.M. Smith, C.A. de Jager, et al. 2010. Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial. PLoS One 5: e12244.
49. Li, M.M., J.T. Yu, H.F. Wang, et al. 2014. Efficacy of vitamins B supplementation on mild cognitive impairment and Alzheimer's disease: a systematic review and meta-analysis. Curr. Alzheimer Res. 11: 844-852.
50. Clarke, R., D. Bennett, S. Parish, et al. 2014. Effects of homocysteine lowering with B vitamins on cognitive aging: meta-analysis of 11 trials with cognitive data on 22, 000 individuals. Am. J. Clin. Nutr. 100: 657-666.
51. Jerneren, F., A.K. Elshorbagy, A. Oulhaj, et al. 2015. Brain atrophy in cognitively impaired elderly: the importance of long-chain omega-3 fatty acids and B vitamin status in a randomized controlled trial. Am. J. Clin. Nutr. 102: 215-221.
52. Gennari, C. 2001. Calcium and vitamin D nutrition and bone disease of the elderly. Public Health Nutr. 4: 547-559.
53. Harms, L.R., T.H. Burne, D.W. Eyles & J.J. McGrath . 2011. Vitamin D and the brain. Best Pract. Res. Clin. Endocrinol. Metab. 25: 657-669.
54. 3 receptors in the central nervous system of the rat embryo. Brain Res. 804: 193-205.
55. 3 regulates the synthesis of nerve growth factor in primary cultures of glial cells. Brain Res. Mol. Brain Res. 24: 70-76.
56. 3 receptor in target cells. Endocrinology 122: 1224-1230.
57. Li, Y.C., G. Qiao, M. Uskokovic, et al. 2004. Vitamin D: a negative endocrine regulator of the renin-angiotensin system and blood pressure. J. Steroid Biochem. Mol. Biol. 89-90: 387-392.
58. Buell, J.S., T.M. Scott, B. Dawson-Hughes, et al. 2009. Vitamin D is associated with cognitive function in elders receiving home health services. J. Gerontol. A Biol. Sci. Med. Sci. 64: 888-895.
59. Buell, J.S., B. Dawson-Hughes, T.M. Scott, et al. 2010. 25-Hydroxyvitamin D, dementia, and cerebrovascular pathology in elders receiving home services. Neurology 74: 18-26.
60. Llewellyn, D.J., I.A. Lang, K.M. Langa, et al. 2010. Vitamin D and risk of cognitive decline in elderly persons. Arch. Intern. Med. 170: 1135-1141.
61. Soni, M., K. Kos, I.A. Lang, et al. 2012. Vitamin D and cognitive function. Scand. J. Clin. Lab. Invest. Suppl. 243: 79-82.
62. van der Schaft, J., H.L. Koek, E. Dijkstra, et al. 2013. The association between vitamin D and cognition: a systematic review. Ageing Res. Rev. 12: 1013-1023.
63. 3 production. Dermatoendocrinology 3: 243-250.
64. Food and Nutrition Board, Institute of Medicine. 2000. Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium, and Carotenoids. Washington, DC: National Academies Press.
65. Fukui, K., K. Nakamura, M. Shirai, et al. 2015. Long-term vitamin E-deficient mice exhibit cognitive dysfunction via elevation of brain oxidation. J. Nutr. Sci. Vitaminol. (Tokyo) 61: 362-368.
66. Morris, M.C., D.A. Evans, J.L. Bienias, et al. 2002. Vitamin E and cognitive decline in older persons. Arch. Neurol. 59: 1125-1132.
67. Dysken, M.W., M. Sano, S. Asthana, et al. 2014. Effect of vitamin E and memantine on functional decline in Alzheimer disease: the TEAM-AD VA cooperative randomized trial. JAMA 311: 33-44.
68. Petersen, R.C., R.G. Thomas, M. Grundman, et al. 2005. Vitamin E and donepezil for the treatment of mild cognitive impairment. N. Engl. J. Med. 352: 2379-2388.
69. Cooney, R.V., A.A. Franke, P.J. Harwood, et al. 1993. Gamma-tocopherol detoxification of nitrogen dioxide: superiority to alpha-tocopherol. Proc. Natl. Acad. Sci. U.S.A. 90: 1771-1775.
70. Mangialasche, F., A. Solomon, I. Kareholt, et al. 2013. Serum levels of vitamin E forms and risk of cognitive impairment in a Finnish cohort of older adults. Exp. Gerontol. 48: 1428-1435.
71. Morris, M.C., J.A. Schneider, H. Li, et al. 2015. Brain tocopherols related to Alzheimer's disease neuropathology in humans. Alzheimers Dement. 11: 32-39.
72. King, J.C., J. Blumberg, L. Ingwersen, et al. 2008. Tree nuts and peanuts as components of a healthy diet. J. Nutr. 138: 1736S-1740S.
73. Grodstein, F., J. O'Brien, J.H. Kang, et al. 2013. Long-term multivitamin supplementation and cognitive function in men: a randomized trial. Ann. Intern. Med. 159: 806-814.
74. Zhang, Y., J. Chen, J. Qiu, et al. 2015. Intakes of fish and PUFAs and mild-to-severe cognitive impairment risks: a dose-response meta-analysis of 21 cohort studies. Am. J. Clin. Nutr. 103: 330-340.
75. Grosso, G. & R. Estruch . 2016. Nut consumption and age-related disease. Maturitas 84: 11-16.
76. Arab, L. & A. Ang . 2015. A cross sectional study of the association between walnut consumption and cognitive function among adult US populations represented in NHANES. J. Nutr. Health Aging 19: 284-290.
77. O'Brien, J., O. Okereke, E. Devore, et al. 2014. Long-term intake of nuts in relation to cognitive function in older women. J. Nutr. Health Aging 18: 496-502.
78. Rita Cardoso, B., D. Apolinario, V. da Silva Bandeira, et al. 2015. Effects of Brazil nut consumption on selenium status and cognitive performance in older adults with mild cognitive impairment: a randomized controlled pilot trial. Eur. J. Nutr. 55: 107-116.
79. Valls-Pedret, C., A. Sala-Vila, M. Serra-Mir, et al. 2015. Mediterranean diet and age-related cognitive decline: a randomized clinical trial. JAMA Intern. Med. 175: 1094-1103.
80. Sanchez-Villegas, A., C. Galbete, M.A. Martinez-Gonzalez, et al. 2011. The effect of the Mediterranean diet on plasma brain-derived neurotrophic factor (BDNF) levels: the PREDIMED-NAVARRA randomized trial. Nutr. Neurosci. 14: 195-201.
81. Wang, X., Y. Ouyang, J. Liu, et al. 2014. Fruit and vegetable consumption and mortality from all causes, cardiovascular disease, and cancer: systematic review and dose-response meta-analysis of prospective cohort studies. BMJ 349: g4490.
82. Lamport, D.J., C. Saunders, L.T. Butler & J.P. Spencer . 2014. Fruits, vegetables, 100% juices, and cognitive function. Nutr. Rev. 72: 774-789.
83. Johnson, E.J. 2012. A possible role for lutein and zeaxanthin in cognitive function in the elderly. Am. J. Clin. Nutr. 96: 1161S-1165S.
84. Shukitt-Hale, B., D.F. Bielinski, F.C. Lau, et al. 2015. The beneficial effects of berries on cognition, motor behaviour and neuronal function in ageing. Br. J. Nutr. 114: 1542-1549.
85. Devore, E.E., J.H. Kang, M.M. Breteler & F. Grodstein . 2012. Dietary intakes of berries and flavonoids in relation to cognitive decline. Ann. Neurol. 72: 135-143.
86. Orhan, I.E., M. Daglia, S.F. Nabavi, et al. 2015. Flavonoids and dementia: an update. Curr. Med. Chem. 22: 1004-1015.
87. Letenneur, L., C. Proust-Lima, A. Le Gouge, et al. 2007. Flavonoid intake and cognitive decline over a 10-year period. Am. J. Epidemiol. 165: 1364-1371.
88. Brickman, A.M., U.A. Khan, F.A. Provenzano, et al. 2014. Enhancing dentate gyrus function with dietary flavanols improves cognition in older adults. Nat. Neurosci. 17: 1798-1803.
89. Ye, X., S.N. Bhupathiraju & K.L. Tucker . 2013. Variety in fruit and vegetable intake and cognitive function in middle-aged and older Puerto Rican adults. Br. J. Nutr. 109: 503-510.
90. Ye, X., X. Gao, T. Scott & K.L. Tucker . 2011. Habitual sugar intake and cognitive function among middle-aged and older Puerto Ricans without diabetes. Br. J. Nutr. 106: 1423-1432.
91. Lowette, K., L. Roosen, J. Tack & P. Vanden Berghe . 2015. Effects of high-fructose diets on central appetite signaling and cognitive function. Front. Nutr. 2: 5.
92. Agrawal, R. & F. Gomez-Pinilla . 2012. 'Metabolic syndrome' in the brain: deficiency in omega-3 fatty acid exacerbates dysfunctions in insulin receptor signalling and cognition. J. Physiol. 590: 2485-2499.
93. Naqvi, A.Z., B. Harty, K.J. Mukamal, et al. 2011. Monounsaturated, trans, and saturated fatty acids and cognitive decline in women. J. Am. Geriatr. Soc. 59: 837-843.
94. Morris, M.C., D.A. Evans, J.L. Bienias, et al. 2004. Dietary fat intake and 6-year cognitive change in an older biracial community population. Neurology 62: 1573-1579.
95. Okereke, O.I., B.A. Rosner, D.H. Kim, et al. 2012. Dietary fat types and 4-year cognitive change in community-dwelling older women. Ann. Neurol. 72: 124-134.
96. Pelletier, A., C. Barul, C. Feart, et al. 2015. Mediterranean diet and preserved brain structural connectivity in older subjects. Alzheimers Dement. 11: 1023-1031.
97. Safouris, A., G. Tsivgoulis, T.N. Sergentanis & T. Psaltopoulou . 2015. Mediterranean diet and risk of dementia. Curr. Alzheimer Res. 12: 736-744.
98. Knight, A., J. Bryan & K. Murphy . 2016. Is the Mediterranean diet a feasible approach to preserving cognitive function and reducing risk of dementia for older adults in Western countries? New insights and future directions. Ageing Res. Rev. 25: 85-101.
99. Morris, M.C., C.C. Tangney, Y. Wang, et al. 2015. MIND diet slows cognitive decline with aging. Alzheimers Dement. 11: 1015-1022.